Perbedaan Indofarma Tbk. dan Zyrexindo Mandiri Buana Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Zyrexindo Mandiri Buana Tbk. diperdagangkan di Rp127 (kapitalisasi pasar 172 M, volume 24 jam 315,2 rb). Perbedaan utamanya: Indofarma Tbk. jauh lebih besar — sekitar 2,3× kapitalisasi pasar Zyrexindo Mandiri Buana Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | ZYRX | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 172 M |
Volume | — | 315,2 rb |
Lot | — | 3,15 rb |
Perputaran | — | 40,04 jt |
Harga Rata-rata | — | 127,02 |
Nilai Transaksi | — | 40,04 jt |
Harga Ekuilibrium Indikatif | — | 127 |
Volume Ekuilibrium Indikatif | — | 400 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Zyrexindo Mandiri Buana Tbk (the Company) is a limited liability company established in Indonesia based on Notarial Deed No. 43 of Jimmy Simanungkalit, S.H., on May 14, 1996. The Company commenced its commercial operations in 1996. The majority shareholder of the Company is Timothy Siddik
Selengkapnya di halaman ZYRX →